Nicole Walker joined Baird Capital's Venture Capital team in 2013 and focuses on early-to-growth stage healthcare investments. Nicole is a current member of the board of directors at Amphora Medical, Elucent Medical, MI Bioresearch, NeoChord, Inc, NeuMoDx Molecular, and Strata Oncology. She is also a Life Science Council member for Springboard Enterprises, an accelerator program dedicated to building high-growth technology-oriented companies led by women.
Prior to joining Baird Capital, Nicole was a venture investor with Abbott focusing on early stage biotech, device, and diagnostic opportunities; and prior to that with Onset Ventures, a Menlo Park, CA firm that specializes in seed & early staged healthcare and tech service investments. Before starting in venture, Nicole served in a number of operating roles. Beginning her career as a reliability & process engineer with Guidant's Advanced Cardiovascular Systems division, she went on to hold a variety of roles within product design, engineering management, and marketing management including roles in Commercial Marketing for Guidant's Asia Pacific operations, based in Hong Kong and in Strategic Marketing for Abbott's OUS discrete and continuous diabetes monitoring brands.
Nicole received a B.S. in Mechanical Engineering from Stanford University and dual Masters Degrees in Business Administration and Engineering Management from the Kellogg School of Management & the McCormick School of Engineering at Northwestern University.